Antidepressants could impact dental implant success

Antidepressant use may be correlated with dental implant failure rates.

In a systematic review and meta-analysis published in The International Journal of Oral & Maxillofacial Implants, investigators searched the PubMed/MEDLINE, Web of Science and Cochrane Central Register of Controlled Trials databases to identify 11 clinical studies focused on the rate of dental implant failure among patients receiving and not receiving antidepressants.

Compared with the patients who didn’t receive antidepressants, the investigators found that the patients who received selective serotonin reuptake inhibitors alone or in combination with other antidepressants were more likely to experience dental implant failure.

The findings highlighted the potential risk antidepressants could pose to dental implants. Further studies are needed to better understand the findings.

Read more: The International Journal of Oral & Maxillofacial Implants

The article presented here is intended to inform you about the broader media perspective on dentistry, regardless of its alignment with the ADA's stance. It is important to note that publication of an article does not imply the ADA's endorsement, agreement, or promotion of its content.